A grim prognosis, a gamble and one patient's fight to defy cancer
Briefly

Katie Doble, after receiving a Stage 4 cancer diagnosis with a prognosis of 16 months to live, grapples with planning her wedding versus her funeral. This story delves into the dilemma many cancer patients face when confronted with dire prognoses and the choice between conventional treatment and participation in clinical trials. As studies show doctors' predictions are often accurate, more patients are increasingly opting for clinical trials despite their associated fears and costs. Doble’s situation exemplifies the emotional turmoil of facing life's uncertainties amid a cancer diagnosis.
Doble's mind drifted away from the details of her illness, consumed instead with conflicting visions of the future. Was she planning her wedding, she wondered, or her funeral?
Each year, thousands of Americans sit in doctor's offices and receive gut-wrenching news. Their lives are speeding toward a cliff, facing the most important decision they'll ever make.
Despite the fear of trying an unproven therapy, the difficulty of finding local studies and the substantial cost of participating in research, more cancer patients are taking the clinical-trial route.
Read at Washington Post
[
|
]